⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ripretinib

Every month we try and update this database with for ripretinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibNCT03673501
Gastrointestina...
Ripretinib
Sunitinib
18 Years - Deciphera Pharmaceuticals LLC
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibNCT03673501
Gastrointestina...
Ripretinib
Sunitinib
18 Years - Deciphera Pharmaceuticals LLC
A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With ImatinibNCT05734105
GIST
Ripretinib
Sunitinib
18 Years - Deciphera Pharmaceuticals LLC
A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced MalignanciesNCT05957367
Colorectal Canc...
GIST
DCC-3116
Ripretinib
Cetuximab
Encorafenib
18 Years - Deciphera Pharmaceuticals LLC
A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced MalignanciesNCT05957367
GIST
DCC-3116
Ripretinib
18 Years - Deciphera Pharmaceuticals LLC
A Study to Assess the Efficacy and Safety of DCC-2618 and Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumors After Treatment With ImatinibNCT04633122
Gastrointestina...
Ripretinib
Sunitinib
18 Years - Zai Lab (Hong Kong), Ltd.
Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib TherapyNCT05132738
Gastrointestina...
Ripretinib trea...
18 Years - 75 YearsRenJi Hospital
A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GISTNCT04530981
GIST - Gastroin...
Ripretinib
Repaglinide
18 Years - Deciphera Pharmaceuticals LLC
The Correlation Between Ripretinib Exposure and the Efficacy and Safety in Patients With Advanced GISTsNCT06431451
Gastrointestina...
18 Years - First Affiliated Hospital, Sun Yat-Sen University
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With ImatinibNCT03673501
Gastrointestina...
Ripretinib
Sunitinib
18 Years - Deciphera Pharmaceuticals LLC
A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced MalignanciesNCT05957367
Colorectal Canc...
GIST
DCC-3116
Ripretinib
Cetuximab
Encorafenib
18 Years - Deciphera Pharmaceuticals LLC
A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GISTNCT04530981
GIST - Gastroin...
Ripretinib
Repaglinide
18 Years - Deciphera Pharmaceuticals LLC
A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GISTNCT04530981
GIST - Gastroin...
Ripretinib
Repaglinide
18 Years - Deciphera Pharmaceuticals LLC
A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With ImatinibNCT05734105
GIST
Ripretinib
Sunitinib
18 Years - Deciphera Pharmaceuticals LLC
A Study to Assess the Efficacy and Safety of DCC-2618 and Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumors After Treatment With ImatinibNCT04633122
Gastrointestina...
Ripretinib
Sunitinib
18 Years - Zai Lab (Hong Kong), Ltd.
Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib TherapyNCT05132738
Gastrointestina...
Ripretinib trea...
18 Years - 75 YearsRenJi Hospital
Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib TherapyNCT05132738
Gastrointestina...
Ripretinib trea...
18 Years - 75 YearsRenJi Hospital
Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GISTNCT04148092
GIST - Gastroin...
ripretinib
18 Years - Deciphera Pharmaceuticals LLC
A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GISTNCT04530981
GIST - Gastroin...
Ripretinib
Repaglinide
18 Years - Deciphera Pharmaceuticals LLC
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: